Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
10/31/2021
10/31/2020
Ingresos
1
1
0
0
0
0
Crecimiento de los Ingresos (YoY)
--
--
--
--
--
--
Costo de los ingresos
0
0
0
0
--
--
Utilidad bruta
0
0
0
0
--
--
Venta, General y Administración
2
1
1
2
0
0
Investigación y Desarrollo
0
0
0
0
--
--
Gastos de Operación
2
1
1
2
0
0
Otras Ingresos (Gastos) No Operativos
--
0
0
0
--
--
Ingreso antes de impuestos
-1
-1
-1
-4
0
0
Gasto por Impuesto a la Renta
--
--
--
--
--
--
Ingreso Neto
-1
-1
-1
-4
0
0
Crecimiento de la Utilidad Neta
0%
0%
-75%
--
--
--
Acciones en Circulación (Diluidas)
51.06
44.31
38.38
35.28
3.18
7.18
Cambio de Acciones (YoY)
14%
15%
9%
1,009%
-56%
20%
EPS (Diluido)
-0.02
-0.02
-0.03
-0.13
-0.03
-0.01
Crecimiento de EPS
-23%
-28.99%
-73%
347%
90%
1,700%
Flujo de efectivo libre
0
0
-1
-1
0
0
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
0%
0%
0%
0%
--
--
Margen de operación
-100%
-100%
0%
0%
0%
0%
Margen de beneficio
-100%
-100%
0%
0%
0%
0%
Margen de flujo de caja libre
0%
0%
0%
0%
0%
0%
EBITDA
-1
-1
-1
-2
--
--
Margen de EBITDA
-100%
-100%
0%
0%
--
--
D&A para EBITDA
0
0
0
0
--
--
EBIT
-1
-1
-1
-2
0
0
Margen de EBIT
-100%
-100%
0%
0%
0%
0%
Tasa de Impuesto Efectiva
--
--
--
--
--
--
Estadísticas clave
Cierre Anterior
$0.2917
Precio de apertura
$0.2298
Rango del día
$0.219 - $0.2299
Rango de 52 semanas
$0.1169 - $0.2937
Volumen
--
Volumen promedio
5.6K
EPS (TTM)
--
Rendimiento de dividendos
--
Cap. de mercado
$13.0M
¿Qué es FRECF?
Frequency Exchange Corp. develops and commercializes frequency emitters. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2020-05-08. The firm is focused on the development and global commercialization of a wearable frequency delivery system. The Company’s specialized frequency sets are designed to enhance wellness and improve performance. The firm offers NIKKI, which is the fifth-generation frequency emitter released by the Company. Its Wave 1 is the third-generation frequency emitter released from FREmedica, specifically to deliver a Frequency Support Program to help clients with the symptoms of chronic Lyme disease. The company also expanded its frequency program through the development of a wearable frequency emitter that delivers special frequency sets designed for the consumer general wellness and performance enhancement market, specifically to target better sleep, less stress and anxiety, pain and inflammation.